Home › Inventors › Jeffrey Browning

JB

Jeffrey Browning — 43 Patents

BMBiogen Ma: 41 patents #3 of 715Top 1%

TGThe Faculty Of Medicine Of The University Of Geneva: 5 patents #1 of 3Top 35%

University of California: 4 patents #2,189 of 18,278Top 15%

NUNew York University: 3 patents #247 of 1,640Top 20%

AAApoxis S. A.: 1 patents #6 of 16Top 40%

UHUniversity Of North Carolina At Chapel Hill: 1 patents #769 of 1,688Top 50%

EUEmory University: 1 patents #549 of 1,217Top 50%

Brookline, MA: #75 of 3,196 inventorsTop 3%

Massachusetts: #1,646 of 88,656 inventorsTop 2%

Overall (All Time): #69,380 of 4,157,543Top 2%

43 Patents All Time

Jeffrey Browning has been granted 43 US patents. The first was granted in 1994 and the most recent in December 2019. Jeffrey Browning ranks #69,380 of 4,157,543 US inventors in our database (top 1.7%). Patent records list Jeffrey Browning in Brookline, MA, US.

Patents per Year

Issued Patents All Time

Showing 1–25 of 43 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10494416	Methods of modulating immune responses using BCMA polypeptide	Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson	2019-12-03	$600,375,000
9650430	Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)	Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson	2017-05-16	$369,423,000
8828669	Methods of screening for a compound that inhibits the interaction between BAFF and BCMA	Christine Ambrose, Fabienne MacKay, Jurg Tschopp, Pascal Schneider, Jeffrey Thompson	2014-09-09
8709759	Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins	Konrad Miatkowski, Werner Meier	2014-04-29
8455445	Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders	Christopher D. Benjamin, Paula S. Hochman	2013-06-04
8338376	Compositions comprising variant LT-B-R-IG fusion proteins	Evan Beckman, Graham K. Farrington, Werner Meier	2012-12-25
8287874	Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases	Paula S. Hochman, Paul Rennert, Fabienne MacKay	2012-10-16
8283138	Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins	Konrad Miatkowski, Werner Meier	2012-10-09
8142779	Treatment of follicular lymphomas using inhibitors of the LT pathway	Jeanette Thorbecke, Vincent Tsiagbe	2012-03-27
8067375	Treatment of demyelinating disorders with soluble lymphotoxin-β-receptor	Jenny P.-Y. Ting	2011-11-29
7951371	Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling	Christopher D. Benjamin, Paula S. Hochman	2011-05-31
7947271	Methods of decreasing tumor volume and reducing tumor burden using TNF-receptor-coupling agents	Veronique Bailly, Ellen Garber	2011-05-24
7846438	Methods of promoting neurite outgrowth with soluble TAJ polypeptides	Sha Mi	2010-12-07
7799902	Receptor coupling agents and compositions thereof	Veronique Bailly, Ellen Garber	2010-09-21
7744891	Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases	Paula S. Hochman, Paul Rennert, Fabienne MacKay	2010-06-29
7731963	TWEAK receptor agonists as anti-angiogenic agents	Linda C. Burkly, Aniela Jakubowski, Timothy Zheng	2010-06-08
7695934	Tumor necrosis factor related ligand	Yves Chicheportiche	2010-04-13
7618933	Treatment of follicular lymphomas using inhibitors of the LT pathway	Jeanette Thorbecke, Vincent Tsiagbe	2009-11-17
7585946	Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions	Konrad Miatkowski, Werner Meier	2009-09-08
7566769	Tumor necrosis factor related ligand	Yves Chicheportiche	2009-07-28
7459537	Anti-lymphotoxin-β receptor antibodies as anti-tumor agents	Werner Meier, Christopher D. Benjamin	2008-12-02
7452530	Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway	Maryann Puglielli, Rafi Ahmed	2008-11-18
7427403	Methods for inhibiting lymphotoxin β receptor signalling	Christopher D. Benjamin, Paula S. Hochman	2008-09-23
7309492	Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of systemic lupus erythematosus	Paula S. Hochman, Paul Rennert, Fabienne MacKay	2007-12-18
7255854	Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases	Paula S. Hochman, Paul Rennert, Fabienne MacKay	2007-08-14